Australia markets closed

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7580+0.0228 (+3.10%)
At close: 1:00PM EST
0.7579 -0.00 (-0.01%)
After hours: 04:41PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
1,281
23.02
0
0
0
Cost of revenue
278.151
86.712
-
-
-
Gross profit
1,002
-63.692
-
-
-
Operating expenses
Research development
658.599
6,555
3,416
4,095
7,137
Selling general and administrative
9,157
6,429
3,738
3,920
4,093
Total operating expenses
9,816
12,984
7,154
8,015
11,231
Operating income or loss
-8,813
-13,047
-7,154
-8,015
-11,231
Interest expense
433.576
112.994
-
-
-
Total other income/expenses net
-
-
-
433.392
-1,005
Income before tax
-9,133
-13,155
-7,126
-7,566
-12,230
Income from continuing operations
-9,133
-13,155
-7,126
-7,566
-12,230
Net income
-9,133
-13,155
-7,126
-7,566
-12,230
Net income available to common shareholders
-9,133
-13,155
-7,126
-7,566
-12,230
Basic EPS
-
-0.52
-0.32
-0.46
-0.82
Diluted EPS
-
-0.52
-0.32
-0.46
-0.90
Basic average shares
-
25,492
22,296
16,602
14,898
Diluted average shares
-
25,492
22,296
16,602
14,951
EBITDA
-
-13,042
-7,154
-8,015
-11,231